Notice of Results

AstraZeneca PLC H1 2016 Results

Tomorrow, Thursday 28 July 2016, AstraZeneca PLC will publish its H1 2016 results at 07:00 UK time.

An analyst presentation will take place at 12:00 UK time and will be accessible by a choice of two routes:

Audio webcast

If you wish to participate in the Q&A session, please dial in five minutes prior to the start time using the numbers and conference code below:

Freephone Local
United Kingdom 0800 279 4992 +44 (0) 20 3140 8286
United States 1877 280 1254 +1 718 354 1157
Sweden 0200 883 440 +46 (0) 8 5352 6408

Conference code: 4185930

Listen-only audio webcast

If you wish to listen to the audio webcast, please dial in five minutes prior to the start time using the numbers and conference code below:

Freephone Local
United Kingdom 0800 279 4977 +44 (0) 20 3427 1917
United States +1 718 354 1158
Sweden +46 (0) 8 5051 3793

Conference code: 4185930

A replay and a transcript from the audio webcast will be made available shortly after the conclusion of the event on http://www.astrazeneca.com/investors.

About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit: www.astrazeneca.com

Subscribe

Documents & Links